Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 27:8:734888.
doi: 10.3389/fmed.2021.734888. eCollection 2021.

Investigation of Correlations Between Optical Coherence Tomography Biomarkers and Visual Acuity in X-Linked Retinoschisis

Affiliations

Investigation of Correlations Between Optical Coherence Tomography Biomarkers and Visual Acuity in X-Linked Retinoschisis

Zhanjie Lin et al. Front Med (Lausanne). .

Abstract

Purpose: To investigate the imaging biomarkers of spectral-domain optical coherence tomography (SD-OCT) and their correlations with age and best-corrected visual acuity (BCVA) in patients with X-linked retinoschisis (XLRS).

Methods: OCT images of 72 eyes of 39 patients with confirmed XLRS were obtained to assess imaging biomarkers, including but not limited to the automatic evaluation of foveal thickness, central subfield thickness (CST), macular volume, and the manual measurement of area of macular schisis cavity (AMS). Correlations between age/BCVA and all OCT parameters were computed as well.

Results: In this study, median age was 10.5 (8-12) years old and median BCVA was 0.90 (0.70-1.00) logarithm of the minimum angle of resolution. Macular retinoschisis was found in all affected eyes, with peripheral retinoschisis (PRS) in 34 (47.2%) eyes. Cystic cavities most frequently affected inner nuclear layer (100%) in the macula. Ellipsoid zone (EZ) defects occurred in 53 (73.6%) eyes. As for correlation, BCVA was significantly correlated with several OCT parameters, including CST, AMS, EZ defect, PRS and vitreomacular adhesion, whereas no correlation was found between age and any OCT parameter.

Conclusion: Explicable OCT imaging biomarkers such as CST, AMS, and photoreceptor defects were identified and may serve as reference parameters or potential regions of interest for future observational and interventional research design and result interpretation.

Keywords: X-linked retinoschisis; biomarker; correlation; optical coherence tomography; visual acuity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The computer user interface of the spectral-domain optical coherence tomography. The foveal thickness (FT), central subfield thickness (CST), and macular volume (MV) were automatically measured by the built-in software of the spectral-domain optical coherence tomography device.
Figure 2
Figure 2
Manual measurement of the area of macular schisis cavity (AMS). The macular schisis cavities were marked by yellow lines and the results were computed by ImageJ software.
Figure 3
Figure 3
Spectral-domain optical coherence tomography image reveals macular schisis cavities in inner nuclear layer (INL), outer plexiform layer (OPL), and outer nuclear layer (ONL). Small cystic cavities were found in the ganglion cell layer (GCL). NFL, nerve fiber layer; IPL, inner plexiform layer; EZ, ellipsoid zone; RPE, retinal pigment epithelium.
Figure 4
Figure 4
Spectral-domain optical coherence tomography image reveals the vitreomacular adhesion (VMA) in the macula (white arrow), with loss of outer retinal layers, and a minimal attenuation of RPE band. But the patient did not have macular atrophy visible in the fundus photograph.
Figure 5
Figure 5
The scatter plots represent the linear correlations between BCVA and structural properties determined by spectral-domain optical coherence tomography.

Similar articles

Cited by

References

    1. Sikkink SK, Biswas S, Parry NR, Stanga PE, Trump D. X-linked retinoschisis: an update. J Med Genet. (2007) 44:225–32. 10.1136/jmg.2006.047340 - DOI - PMC - PubMed
    1. Molday RS, Kellner U, Weber BH. X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms. Prog Retin Eye Res. (2012) 31:195–212. 10.1016/j.preteyeres.2011.12.002 - DOI - PMC - PubMed
    1. Gao FJ, Dong JH, Wang DD, Chen F, Hu FY, Chang Q, et al. . Comprehensive analysis of genetic and clinical characteristics of 30 patients with X-linked juvenile retinoschisis in China. Acta Ophthalmol. (2020) 99:e470–9. 10.1111/aos.14642 - DOI - PMC - PubMed
    1. De Silva SR, Arno G, Robson AG, Fakin A, Pontikos N, Mohamed MD, et al. . The X-linked retinopathies: physiological insights, pathogenic mechanisms, phenotypic features and novel therapies. Prog Retin Eye Res. (2020) 2020:100898. 10.1016/j.preteyeres.2020.100898 - DOI - PubMed
    1. Salvatore S, Fishman GA, Genead MA. Treatment of cystic macular lesions in hereditary retinal dystrophies. Surv Ophthalmol. (2013) 58:560–84. 10.1016/j.survophthal.2012.11.006 - DOI - PubMed